乌苯美司;58970-76-6;Bestatin 新品

产品描述

CAS号：58970-76-6

分子式：C16H24N2O4

分子量：308.37

EINECS号：261-529-2

产品用途

乌苯美司现与多种化药联合用于治疗肿瘤，效果明显。近期研究表明，乌苯美司联合化疗药物5-氟尿嘧啶、阿霉素、亚叶酸钙等治疗肝动脉栓塞中晚期复发性肝癌（尤其是肿瘤直径<3cm及3~5cm的小肝癌）时，会增强细胞凋亡以及细胞内活性氧水平，治疗效果优于单纯化疗。对于晚期胃癌，与替吉奥联合奥沙利铂化疗方案联用后，乌苯美司能降低患者血清MMP2及MMP9水平，增强抗肿瘤效果。乌苯美司还可加强全反式维甲酸对急性早幼粒细胞白血病细胞增殖的抑制作用及诱导细胞分化的能力。

联系方式

四川青木制药有限公司

四川省眉山市东坡区经济开发区东区顺江大道南段55号

国际营销部(International):

Email: sales@eastonpharma.cn 

Tel: 028-87827187

国内营销部(Mainland)：

李经理 13880480517   

杨经理 15982276454

Product Description

CAS number：58970-76-6

Molecular formula ：C16H24N2O4

Molecular weight ：308.37

EINECS number ：261-529-2

Applications 

Ubenmex is now used in combination with a variety of chemical drugs in the treatment of tumor, the effect is obvious. Recent studies have shown that ubenmex combined with chemotherapy drugs such as 5-fluorouracil, doxorubicin and calcium leucovorin can enhance cell apoptosis and intracellular reactive oxygen species in the treatment of advanced recurrent liver cancer (especially small liver cancer with tumor diameter <3cm and 3~5cm), and the therapeutic effect is better than that of chemotherapy alone. For advanced gastric cancer, when combined with Tighio and oxaliplatin chemotherapy regimen, Ubenamex can reduce serum MMP2 and MMP9 levels and enhance the anti-tumor effect. Ubenomex also enhanced the inhibitory effect of all-trans retinoic acid on the proliferation of acute promyelocytic leukemia cells and the ability of inducing cell differentiation.

Contact Information

Sichuan Qingmu Pharmaceutical Co., Ltd.

Add: No. 55, South Shunjiang Avenue, East Economic Development Zone, Dongpo District, Meishan City, Sichuan, 620036, China

International Marketing Department: 

Email: sales@eastonpharma.cn 

Tel: 0086-28-87827187